Navigation Links
Unigene and Tarix Pharmaceuticals Report Highly Increased Oral Bioavailability of "Peptelligence-engineered" TXA127
Date:9/19/2012

x's development of PanCyte.  These forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various risk factors. These known and unknown risk factors include, but are not limited to, the risk factors discussed in our Securities and Exchange Commission ("SEC") filings, including our annual report on Form 10-K and our quarterly reports on Form 10-Q. Words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "potential," "continue," and variations of these words (or negatives of these words) or similar expressions, are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements. In addition, any statements that refer to expectations, projections, contingencies, goals, targets or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements and are not statements of historical fact. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the SEC, we are under no obligation to publicly update or revise any forward-looking statements after the date of this release.

For Investors & Media:
Joshua Drumm, Ph.D. / Jason Rando
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jdrumm@tiberend.com
jrando@tiberend.com


'/>"/>
SOURCE Unigene Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Unigene to Present at TIDES 2012
2. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
3. Unigenes Oral PTH Phase 2 Proof-of-Concept Data to be Presented at Upcoming Scientific Conferences
4. Unigene Provides Update Following Recent EMA Recommendation on Calcitonin-Containing Medicines
5. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
6. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
7. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
8. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
9. Icahn Issues Statement Regarding Amylin Pharmaceuticals
10. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
11. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals announced ... KX2-361 at Roswell Park Cancer Institute. KX2-361 ... drug that has shown potent inhibitory activity against a ... that are resistant to Temozolomide (T98G), the most widely ... a well-established brain tumor mouse model, KX2-361 consistently clears ...
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, ... PTN), a biopharmaceutical company developing targeted, receptor-specific peptide ... unmet medical need and commercial potential, today announced ... of 2,050,000 shares of its common stock and ... its common stock.  Funds under the management of ...
(Date:12/24/2014)... DIEGO , Dec. 23, 2014 ResMed (NYSE: ... significant patent infringement action against Chinese medical device manufacturer BMC ... (ITC) ruled today that BMC,s masks listed below infringe ResMed,s ... or selling these masks in the United States ... iVolve N2 nasal mask , Willow nasal pillows mask ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2
... HealthWarehouse.com , Inc. (OTC: HEWA), a leading ... its pre-order program to enable consumers immediate access to Atorvastatin ... offer the medication at up to 50 percent less ... "We will be one of the earliest and ...
... Nov. 29, 2011  In a new study presented today at ... (RSNA), growth hormone replacement for six months was found to ... is the first time that the effects of growth hormone ... lead author, Miriam A. Bredella, M.D., a radiologist at Massachusetts ...
Cached Medicine Technology:HealthWarehouse.com Offers Lowest Price Generic Lipitor on the Market 2HealthWarehouse.com Offers Lowest Price Generic Lipitor on the Market 3Growth Hormone Increases Bone Formation in Obese Women 2
(Date:12/25/2014)... 2014 Recently, LunaDress.co.uk has updated its blog to ... accessories. Now, all of the models at LunaDress.co.uk come with big ... lifts the wedding veil can turn out to be a most ... wedding veil can always bring surprise to a wedding. On the ... to choose veils for a big day . , Going ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... 24, 2014 (HealthDay News) -- Among early stage breast ... than half of one percent will eventually develop leukemia ... reveals. The finding comes from a review of ... and 2007, and it suggests that the risk for ... experts had previously thought. "The frequency of bone ...
(Date:12/25/2014)... December 25, 2014 AngelWeddingDress.com tries its ... the online realm. Today, the business has introduced its ... site-wide prom dress promotion. , The new prom outfits ... and every dress lover. They are specially designed for ... prom dresses should visit its website before Jan. ...
(Date:12/25/2014)... SmileStix ” was featured on NewsWatch as part of its ... on the iOS, Android, and Windows markets. Andrew Tropeano, a ... review and shared with viewers how this is an application ... goes, “A picture says a thousand words.” It’s true. There ... image, because each picture holds a unique and special meaning. ...
Breaking Medicine News(10 mins):Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... HCA today announced financial,and operating results for the third quarter ... increased 5.7 percent to $6.569 billion. -- Adjusted EBITDA totaled ... the prior year. -- Net income totaled $300 million, ... year. -- Interest expense increased to $560 million, up from ...
... in 2008, HOUSTON, Nov. 7 In ... and RediClinic Services units of RediClinic,LLC have been ... have been promoted and two new executives have ... chief operating officer of the RediClinic,division, has been ...
... America, the premier network,of diabetes care and management centers ... its physicians have been recognized by the,Diabetes Physician Recognition ... Dr. Wendy Hawkins M.D., Dr. Damon,Weddington M.D., Dr. Alice ... M.D. were all honored in Houston today. "The ...
... Inc. (Amex:,ADL), with operations in Shenzhen, Jiangxi and ... Inc. (JPI), which is an,international biopharma company that ... pharmaceutical and diagnostic,products, announced today that JPI,s subsidiary ... agreements for its new anti-aging and skin,care injectable ...
... at 8:00 a.m. ET -, VALENCIA, Calif., Nov. ... financial results for the third quarter ended,September 30, 2007. ... expenses were $75.6,million, compared to $61.1 million for the ... was attributed to increased research,and development (R&D) expenses which ...
... Insulet Corporation,(Nasdaq: PODD ), the manufacturer and marketer ... of its public offering of,4,898,398 shares of common stock ... by selling stockholders. Insulet will not receive any proceeds,from ... has granted to,the underwriters an option to purchase up ...
Cached Medicine News:Health News:HCA Reports Third Quarter 2007 Results 2Health News:HCA Reports Third Quarter 2007 Results 3Health News:HCA Reports Third Quarter 2007 Results 4Health News:HCA Reports Third Quarter 2007 Results 5Health News:HCA Reports Third Quarter 2007 Results 6Health News:HCA Reports Third Quarter 2007 Results 7Health News:HCA Reports Third Quarter 2007 Results 8Health News:HCA Reports Third Quarter 2007 Results 9Health News:HCA Reports Third Quarter 2007 Results 10Health News:HCA Reports Third Quarter 2007 Results 11Health News:HCA Reports Third Quarter 2007 Results 12Health News:HCA Reports Third Quarter 2007 Results 13Health News:HCA Reports Third Quarter 2007 Results 14Health News:RediClinic Announces Management Changes 2Health News:RediClinic Announces Management Changes 3Health News:Diabetes America Physicians Achieve Industry Recognition for Quality Patient Care 2Health News:AMDL Launches Expanded Distribution With 4th Round of Agreements Valued at $6.79 Million Annually for New Health & Beauty Product Line 2Health News:MannKind Corporation Reports Third Quarter Financial Results 2Health News:MannKind Corporation Reports Third Quarter Financial Results 3Health News:MannKind Corporation Reports Third Quarter Financial Results 4Health News:MannKind Corporation Reports Third Quarter Financial Results 5Health News:MannKind Corporation Reports Third Quarter Financial Results 6Health News:Insulet Corporation Announces Pricing of Secondary Public Offering 2
System, English (Continental cord), 230 VAC....
Portable mini halogen light....
Micro-mini fiber optic light....
Miniature high intensity fiber optic light. The ultra-thin fiber-optic cable is smaller and lighter than a standard electrical cord....
Medicine Products: